NEW YORK, May 7 – Venlo, Netherlands-based Qiagen announced today that its net revenues and net income were up for the first quarter ending March 31.

The company reported net sales of $80 million, compared to $70.5 million for the year-ago quarter. The firm had net income of $11 million, compared to $9.5 million for the same quarter in 2002.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.